Investigation of some chemotherapy drugs induce cardiotoxicity

Investigation of some chemotherapy drugs induce cardiotoxicity

The risk of long-term cardiovascular problems resulting from cancer treatment is rising due to the growing population of cancer patients. Cancer therapy-induced cardiotoxicity (CTIC) is a partially elucidated consequence of diverse chemotherapeutic drugs, targeted anti-cancer treatments, and radiat...

Full description

Saved in:

Bibliographic Details
Main Authors:	Asia A. Mahdi, Basma H. Bedair, Ashjan M. Hussein, Alyaa K. Abood, Rabiah M. Sabri, Shams A. Mohammed, Eman G. Metaab, Reem H. Al-Tabra, Nada H. Bedair, Moustafa A. Gouda, Asmaa A. Jawad, Abbas K. Abbas
Format:	Article
Language:	English
Published:	Alsalam university college 2025-08-01
Series:	Al-SalamJournal for Medical Science
Subjects:	Cardiotoxicity; Chemotherapy; Heart failure; Cardio protection; CTIC
Online Access:	http://journal.alsalam.edu.iq/index.php/ajbms/article/view/470
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Nuclear imaging of chemotherapy-induced cardiotoxicity
by: A. A. Ansheles, et al.
Published: (2021-03-01)

New opportunities for preclinical diagnostics of antitumor therapy cardiotoxicity: results of an observational study
by: Yu. A. Vasyuk, et al.
Published: (2025-08-01)

5-Oxoproline prevents doxorubicin-induced cardiotoxicity and tumor growth
by: Xinning Guo, et al.
Published: (2025-09-01)

Lifestyle and Pharmacological Interventions to Prevent Anthracycline-Related Cardiotoxicity in Cancer Patients
by: Luigi Spadafora, et al.
Published: (2025-06-01)

Atrial Fibrillation in Cancer Patients: Who is at Risk?
by: Yu. A. Vasyuk, et al.
Published: (2022-01-01)

Cardiotoxicity of Anticancer Drugs
by: I. Maiborodin, et al.
Published: (2025-02-01)

A multimodality score strategy for assessing the risk of immune checkpoint inhibitors related cardiotoxicity
by: Zhulu Chen, et al.
Published: (2024-10-01)

AI and Smart Devices in Cardio-Oncology: Advancements in Cardiotoxicity Prediction and Cardiovascular Monitoring
by: Luiza Camelia Nechita, et al.
Published: (2025-03-01)

Relationship between Chemotherapy and Atrial Fibrillation: Clinical Case
by: A. A. Avagimyan, et al.
Published: (2021-11-01)

Novel molecular biomarkers of cancer therapy‐induced cardiotoxicity in adult population: a scoping review
by: Irene Cartas‐Espinel, et al.
Published: (2022-06-01)

Detecting subclinical cardiotoxicity during immune checkpoint inhibitor therapy: a combined GLS and ECG repolarization analysis
by: Dogac Oksen, et al.
Published: (2025-07-01)

Doxorubicin-Induced Cardiotoxicity and the Emerging Role of SGLT2 Inhibitors: From Glycemic Control to Cardio-Oncology
by: Iacob-Daniel Goje, et al.
Published: (2025-05-01)

Heart failure in cancer patients
by: A. F. Khalirakhmanov, et al.
Published: (2022-01-01)

Frequency of cardiotoxicity following intramuscular administration of epinephrine in emergency department patients with anaphylaxis
by: Emily K. Pauw, et al.
Published: (2024-02-01)

Cardioprotective effect of thiotriazoline in cancer patients
by: A. V. Koltsov, et al.
Published: (2023-02-01)

Atrial fibrillation in a patient with lung cancer: a case report
by: E. Yu. Shupenina, et al.
Published: (2022-12-01)

Independent and Incremental Value of ECG Markers for Prediction of Cancer Therapy‐Related Cardiac Dysfunction
by: Ishmam Ibtida, et al.
Published: (2025-05-01)

Carbamazepine Cardiotoxicity
by: J Gordon Millichap
Published: (1993-10-01)

Investigation of cardiotoxic effects of marbofloxacin
by: Devran Coşkun, et al.

CHEMOTHERAPY CARDIOTOXICITY SCREENING WITH CARDIAC TROPONINS
by: O. V. Krikunova, et al.
Published: (2015-12-01)

Trastuzumab and cardiotoxicity
by: Petra Sertić, et al.
Published: (2024-01-01)

Evaluation of cardiovascular comorbidity in cancer patients and analysis of potential risk factors for cardiovascular complications of checkpoint inhibitor therapy
by: E. A. Kushnareva, et al.
Published: (2022-01-01)

Cancer Therapy-Related Cardiac Dysfunction: Strategies for Enhancing Cardiac Recovery
by: Pavel Martinez-Dominguez, et al.
Published: (2024-08-01)

Advances in Targeted Autophagy Modulation Strategies to Treat Cancer and Associated Treatment-Induced Cardiotoxicity
by: Lauren A. Ling, et al.
Published: (2025-05-01)

Cardiotoxicity in Children With Acute Ieukemia Treated by Anthracycline; Detected by Cardiac Troponins and Echcocardiography
by: Yaran Abbas Abdulqader, et al.
Published: (2023-04-01)

Therapeutic Potential of Ginsenosides in Anthracycline-Induced Cardiotoxicity
by: Rongrong Bai, et al.
Published: (2025-06-01)

Cardiac Adverse Events in Patients Receiving Immune Checkpoint Inhibitors in the Adjuvant Setting: An FDA Pooled Analysis
by: Asma Dilawari, et al.
Published: (2025-05-01)

Cardiotoxicity in chemotherapeutic agents
by: Vitorino Modesto dos Santos, et al.
Published: (2021-03-01)

Electrocardiographic changes in QTc interval and other parameters associated with osimertinib therapy
by: Yilin Pan, et al.
Published: (2025-06-01)

Сonsensus statement of Russian experts on the prevention, diagnosis and treatment of cardiotoxicity of anticancer therapy
by: Yu. A. Vasyuk, et al.
Published: (2021-10-01)

The Use of Cardio Training in a Comprehensive Rehabilitation Program for Patients with Breast Cancer: a Review
by: Ksenia A. Blinova, et al.
Published: (2025-01-01)

Preclinical characterisation of changes in cardiac function and circulating biomarkers following differential irradiation of thoracic volumes
by: Refik Kuburas, et al.
Published: (2025-06-01)

Effect of pimobendan on cytokine levels in doxorubicin-induced cardiotoxicity
by: Burak Dik, et al.

Impact of a cardio‐oncology unit on prevention of cardiovascular events in cancer patients
by: Alessandra Cuomo, et al.
Published: (2022-06-01)

The role of doxorubicin in the formation of cardiotoxicity is a consensus statement. Part II. Cardiotoxicity of doxorubicin unrelated to myocytes and cardioprotection strategy (review)
by: D. A. Andreev, et al.
Published: (2024-09-01)

Multidisciplinary strategies to reduce radiotherapy-induced cardiotoxicity in breast cancer: surgical and technological innovations
by: Kai Lu, et al.
Published: (2025-08-01)

Changes of myocardial dysfunction and injury biomarkers over chemotherapy for multiple myeloma: difficulties in laboratory data interpretation
by: E. V. Fomina, et al.
Published: (2023-11-01)

Investigate if Metoprolol and Troxerutin Could Prevent Cardiotoxicity Mitigated by Doxorubicin
by: Fouad Zeidan Hamzah, et al.
Published: (2025-07-01)

Natural strategies of preventing anthracycline-induced cardiotoxicity – a review
by: Anca STOICA, et al.
Published: (2022-12-01)

Cardiotoxicity of Chemotherapeutic Drugs (Literature Review and Clinical Case Description)
by: Avagimyan Ashot A., et al.
Published: (2019-12-01)